Afrezza
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Treatment with Afrezza® (insulin human) inhalation powder in individuals with type 1 diabetes (T1D) reduces HbA1c levels similar…
Technosphere insulin (TI), Afrezza, is a powder form of short-acting regular insulin taken by oral inhalation with meals. Action…
Afrezza is rapid-acting oral inhalation insulin that is administered at the beginning of each meal. The U.S Food and Drug…
MannKind has found a deep-pocketed business partner to market its inhaled insulin therapy, Afrezza (Technosphere insulin). On…
NEW DRUG APPROVALS Inhaled Insulin Afrezza For Diabetes The FDA has approved a rapid-acting inhaled insulin to improve glycemic…
* Afrezza (insulin human) is a newly approved fast-acting inhaled insulin. It can be used in treating type 1 diabetes when added…
FDA and MannKind Corp. on June 27 announced the approval of Afrezza inhalation powder, a new rapid-acting recombinant human…
MannKind has found a deep-pocketed business partner to market its inhaled insulin therapy, Afrezza (Technosphere insulin). On…
analog, that is more rapid in onset and shorter duration compared with regular human insulin. For those who fear needles, the…
volume 29 number 3 mArCH 2011 nature biotechnology Skyler says. Afrezza could also ease concerns about potential effects on the…